OncoSec Medical CEO Daniel O'Connor's 2019 pay falls 72% to $1.2M
OncoSec Medical reports 2019 executive compensation
By ExecPay News
Published: April 30, 2020
OncoSec Medical reported fiscal year 2019 executive compensation information on April 30, 2020.
In 2019, two executives at OncoSec Medical received on average a compensation package of $852K, a 61% decrease compared to previous year.
Average pay of disclosed executives at OncoSec Medical
Daniel J. O'Connor, Chief Executive Officer, received $1.2M in total, which decreased by 72% compared to 2018. 39% of O'Connor's compensation, or $454K, was in salary. O'Connor also received $250K in bonus, $450K in stock awards, as well as $23K in other compensation.
Sara Bonstein, Chief Financial Officer, received a compensation package of $526K, which decreased by 43% compared to previous year. 70% of the compensation package, or $369K, was in salary.
OncoSec Medical's fiscal year ends on July 31.
Related executives
You may also like
Source: SEC filing on April 30, 2020.